Cosentyx (ecukinumab rch) is now also indicated for the treatment of adult patients with active psoriatic arthritis when the response to previous disease‑modifying anti‑rheumatic drug (DMARD) therapy has been inadequate. Cosentyx is now also indicated in the treatment of adult patients with active ankylosing spondylitis.
Truvada (tenofovir disoproxil fumarate; emtricitabine) is now also indicated in combination with safer sex practices for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV‑1 in adults at high risk. This indication is based on clinical trials in men who have sex with men (MSM) at high risk for HIV‑1 infection and in heterosexual serodiscordant couples.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629